HM Payson & Co’s BIND THERAPEUTICS INC BIND Stock Holding History

HM Payson & Co’s Portfolio BIND Stock Details BIND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-30,000	Closed	-$66K	–	348
2016 Q1	$66K	Buy	+30,000	New	+$54.4K	﹤0.01%	329

Other funds holding BIND

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

HM Payson & Co's BIND Position: Q2 2016 in Review

HM Payson & Co sold out of BIND THERAPEUTICS INC (BIND) in Q2 2016, closing a stake of 30,000 shares — an estimated $66K sold.

HM Payson & Co first reported a position in BIND in Q1 2016 and held it in 1 quarter. The position peaked at $66K in Q1 2016. 21 funds tracked by Wall St. Rank hold BIND as of Q2 2016.

HM Payson & Co reported no remaining BIND THERAPEUTICS INC position as of Q2 2016 after selling out during the quarter.
HM Payson & Co sold 30,000 BIND THERAPEUTICS INC shares in Q2 2016, an estimated $66K.
HM Payson & Co first reported a position in BIND THERAPEUTICS INC in Q1 2016 and held it in 1 quarter.
HM Payson & Co's BIND THERAPEUTICS INC position peaked at $66K in Q1 2016.
21 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2016.

Based on HM Payson & Co's 13F filing for Q2 2016, filed 8 Aug 2016.